8 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
14 Dec 23
Current report (foreign)
6:01am
of Board Effectiveness - Supplementary Principle 4.11.3 An evaluation of the performance and effectiveness of the BOD is conducted once a year by third
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
12 Jul 23
Current report (foreign)
6:07am
visits, as necessary. The Company bears the expenses for all the training mentioned above. p. Analysis and Evaluation of Board Effectiveness - Supplementary
6-K
TAK
Takeda Pharmaceutical Co
11 Jul 22
Current report (foreign)
6:05am
and Evaluation of Board Effectiveness - Supplementary Principle 4.11.3
An evaluation of the performance and effectiveness of the Board of Directors
6-K
TAK
Takeda Pharmaceutical Co
1 Nov 21
Current report (foreign)
6:04am
the foregoing training.
p.Analysis and Evaluation of Board Effectiveness… Supplementary Principle 4.11.3
An evaluation of the performance
6-K
TAK
Takeda Pharmaceutical Co
19 Jul 21
Current report (foreign)
6:02am
of Board Effectiveness… Supplementary Principle 4.11.3
An evaluation of the performance and effectiveness of the Board of Directors is conducted once
6-K
z0m1zrhwwpj
16 Jul 19
Current report (foreign)
8:50am
6-K
c9i0haca7
14 Jun 19
Current report (foreign)
6:17am
6-K
ijqzb7hlna 195
31 Jan 19
Current report (foreign)
6:07am
- Prev
- 1
- Next